KOR

e-Article

Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.
Document Type
article
Source
Infection and Immunity. 63(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Immunization
Vaccine Related
Vector-Borne Diseases
Infectious Diseases
Biotechnology
Good Health and Well Being
Animals
Antibodies
Protozoan
Chagas Disease
Female
Flagella
Humans
Mice
Mice
Inbred BALB C
Protozoan Proteins
Protozoan Vaccines
Survival Analysis
Vaccination
Biological Sciences
Agricultural and Veterinary Sciences
Medical and Health Sciences
Microbiology
Immunology
Medical microbiology
Language
Abstract
The paraflagellar rod proteins (PAR) purified from Trypanosoma cruzi epimastigotes were shown to protect mice against an otherwise lethal challenge inoculum of 10(3) bloodstream-form trypomastigotes. The injection route used for immunization was shown to have a marked impact on the development of protective immunity. Mice receiving subcutaneous (s.c.) injections of PAR proteins had reduced bloodstream parasitemias and showed 100% survival following challenge. In contrast, mice immunized via the intraperitoneal (i.p.) route developed parasitemia levels equivalent to those of unimmunized controls and did not survive infection. Western blotting (immunoblotting) demonstrated that sera from both i.p. and s.c. immunized mice reacted specifically with PAR proteins; however, the antibody titer of the i.p. immunized mice was approximately 64-fold greater than that of the s.c. immunized mice, suggesting that the protective response in the s.c. immunized mice is cell mediated rather than humoral.